logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


Sarepta Pharmaceuticals Jumps on Competitor’s Failure

  +Follow August 16, 2013 9:54AM
Share:
Tickers Mentioned:

Sarepta Therapeutics Inc. (SRPT) experienced a bit of schadenfreude on Aug. 16 as a direct competitor stumbled badly at the finish line.

Competitor GlaxoSmithKline plc (GSK) had been neck-and-neck with Serepta in the race to develop a breakthrough muscle disorder drug to treat Duchenne Muscular Dystrophy. Both drugs were far ahead of the pack in the development process.

That is, until Baird analyst Brian Skorney reported that Glaxo’s drug, drisapersen, has encountered major stumbling blocks on several fronts that could significantly hamper development. Skorney cited clinical, regulatory, and commercials issues with the drug. Most importantly, the drug did not seem to effectively treat symptoms of the disease at the targeted dose.

Serepta’s drug, eteplirsen, so far has seemed to be effective at treating symptoms of Duchenne. Clinical trials have taken place in the UK. On Aug. 7 the company released promising clinical trial information, which will form the basis of their application for US FDA approval in early 2014.

Duchenne is a severely debilitating form of muscular dystrophy. The recessive muscular degenerative disorder affects approximately 1 in 3,600 boys, and life expectancy for sufferers is usually around 25. A drug from either company would be the first on the American market designed to treat the disorder.

The London-based GlaxoSmithKline , which is the fourth largest pharmaceutical company in the world, shrugged off the setback. Their stock is up .33 percent to hit $51.70 a share.

Serepta is up 6.77 percent to hit $34.21 a share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for GSK
Michael Cook
7 Jul 15 21:40:59
$GEQU Nearly Doubled For Our Platinum Members In 5 Days! Subscribe To Get Our Next Pick Early: http://t.co/seztEzzI8Y $LFAP $GSK $ROX
Breaking News Now
7 Jul 15 21:24:03
$GSK: Shares of GlaxoSmithKline PLC (NYSE:GSK) Sees Large Inflow of ...: http://t.co/tC6678U70T
Stock Rocket
7 Jul 15 20:29:54
Our Penny Stock Newsletter Alerts Gained 200% In 2 Weeks! Get Our Next Pick Early: http://t.co/4eX1MHBloV $LFAP $GSK $ROX
poly
7 Jul 15 18:48:32
? @microbiomom so #vaccines information is only valid if it supports #vaccine industry positions? $MRK $GSK #OpWallSt #OWS #SB277 #OpWeb9
Michael Cook
7 Jul 15 18:28:21
$GEQU Nearly Doubled For Our Platinum Members In 5 Days! Subscribe To Get Our Next Pick Early: http://t.co/seztEzzI8Y $LFAP $GSK $ROX
Michael James
7 Jul 15 18:27:11
Our Stock Alerts On $GEQU Gained As Much As 83.33% For Our Members, In the Past 5 Days! Big News: http://t.co/121SdGPPTC $LFAP $GSK $ROX
Tricia Dineen
7 Jul 15 17:56:37
@TradeTexasBig --- my BUG & FLU list-- $AKAO, $CEMP, $PRTK, $TTPH .....$BCRX, $NVAX, $HEB, $SNY, $NBY, $MDCO, $GSK, $ENTA..
Penny Stockington
7 Jul 15 17:48:44
$SUTI Has Gained 66.67%, Since Our Penny Stock Blog Alert! Huge News: http://t.co/llIxl7cUOL $LFAP $GSK $ROX
Stock Rocket
7 Jul 15 17:26:49
Our Penny Stock Newsletter Alerts Gained 200% In 2 Weeks! Get Our Next Pick Early: http://t.co/4eX1MHBloV $LFAP $GSK $ROX
Stock Dawgzz
7 Jul 15 17:16:43
Our Platinum Subscribers Saw Their Penny Stock Alerts Gain Over 200% In 2 Weeks! Big Update: http://t.co/Lhta1yqlzk $LFAP $GSK $ROX
David J Kroll
7 Jul 15 17:14:46
.@bioinformer @Namaste_Ish @rinjikou @drugmonkeyblog @andpru we're lucky to have Jason @TriBizHealth. $GSK $PRXL ex: http://t.co/M1Fq2Ba53E
Drug Monkey
7 Jul 15 17:08:31
RT @davidkroll: .@rinjikou @Namaste_Ish @drugmonkeyblog @andpru Funny you mention CROs. Some $GSK folks were picked up by Paraxel. They jus…
David J Kroll
7 Jul 15 17:07:33
.@rinjikou @Namaste_Ish @drugmonkeyblog @andpru Funny you mention CROs. Some $GSK folks were picked up by Paraxel. They just unloaded peeps.
Jonathan Jacobs
7 Jul 15 17:05:51
RT @davidkroll: @Namaste_Ish @rinjikou @drugmonkeyblog @andpru re pharma techs, great pay if you actually have a job. Massive slashing of R…
Drug Monkey
7 Jul 15 16:59:16
RT @davidkroll: @Namaste_Ish @rinjikou @drugmonkeyblog @andpru re pharma techs, great pay if you actually have a job. Massive slashing of R…
David J Kroll
7 Jul 15 16:53:21
@Namaste_Ish @rinjikou @drugmonkeyblog @andpru re pharma techs, great pay if you actually have a job. Massive slashing of R&D jobs here $GSK
Paul Henry
7 Jul 15 15:55:20
Our Penny Stock Picks Have Gained 3,600% In 9 Months! Subscribe To Get Our Future Picks: http://t.co/0VyTzPR97b $LFAP $GSK $ROX
Peter Pham
7 Jul 15 14:54:03
$MNKD MannKind's Afrezza Lags Behind Biggest Failure in Inhaled Insulin Here's a graphical repres $MNKD $GSK $IMS http://t.co/sAFDCKITVp
Michael James
7 Jul 15 14:30:53
Our Penny Stock Pick On $GEQU Gained 83.33% For Platinum Members, In the Past 5 Days! Big News: http://t.co/Lsygm1nyn3 $LFAP $GSK $ROX
Penny Stockington
7 Jul 15 13:59:28
$SUTI Has Gained 66.67%, Since Our Penny Stock Blog Alert! Huge News: http://t.co/llIxl7cUOL $LFAP $GSK $ROX
BUD RANTE
7 Jul 15 13:06:09
@DDRANTE $PBMD Nice close 35% LAG3 Stay very Long Look & be inspired with $KITE $JUNO $ADRO $TSRO $BMY #Our Partners #IMP 731-701 $GSK $NVS
StockenheimerSchmidt
7 Jul 15 12:56:56
Our Stock Pick On $PPCH Is Up 370% For Our Subscribers, Since Our Original Release At .02! Huge News: http://t.co/Ab9x726B1J $LFAP $GSK $ROX
Stock Dawgzz
7 Jul 15 12:47:27
Our Platinum Subscribers Saw Their Penny Stock Alerts Gain Over 200% In 2 Weeks! Big Update: http://t.co/Lhta1y8KaK $LFAP $GSK $ROX
Stockaholics
7 Jul 15 12:45:15
$SUTI Has Now Seen 400% Gains In The Past 2 Weeks! Special Update: http://t.co/l1zbyeF3OQ $LFAP $GSK $ROX
Stock Rocket
7 Jul 15 12:44:36
Our Penny Stock Newsletter Alerts Gained 200% In 2 Weeks! Get Our Next Pick Early: http://t.co/4eX1MHBloV $LFAP $GSK $ROX
Paul Henry
7 Jul 15 12:23:03
Our Penny Stock Picks Have Gained 3,600% In 9 Months! Subscribe To Get Our Future Picks: http://t.co/0VyTzPR97b $LFAP $GSK $ROX
greenday
7 Jul 15 11:45:29
$AMRN won NCE. If they also gain the right to promote Anchor let the EU partnership bidding begin. PFE? $GSK? How about $AZN?
BUD RANTE
7 Jul 15 11:25:48
@DDRANTE $PBMD August or September #Due for Ph1 update from our #Partners $GSK = #IMP 731 $NVS = IMP 701 #Milestone payments-Who knows?
Ben Obadia
7 Jul 15 09:16:29
$GSK again on the volume
BNK Invest
7 Jul 15 09:09:05
Video: Tuesday's ETF with Unusual Volume: $IDLV $T $GSK $GPT $ANDR #stocks http://t.co/Sbuc1mfvGq
Paul Henry
7 Jul 15 09:05:26
Our Penny Stock Picks Have Gained 3,600% In 9 Months! Subscribe To Get Our Future Picks: http://t.co/0VyTzPR97b $LFAP $GSK $ROX
shmittahcapital
7 Jul 15 09:01:15
In the Golden age of Pharma $GSK sitting on 3 year low..
Ben Obadia
7 Jul 15 08:40:00
$GSK catching a major bid here
BlockTradeAlert
7 Jul 15 08:31:17
BLOCK TRADE: $GSK 625,000 shares @ $41.54 [11:31:16]
Veronica Nadan
7 Jul 15 08:21:10
RT @P01YN0NYM0U55: ! @gnudarwin #California #SB277 is being used as test run for national law. Gotta tag #Merck and #GlaxoSmithKline ticker…
BreakingStocksNews
7 Jul 15 08:19:03
$AMRN $GSK: Amarin Corporation plc (ADR) (NASDAQ:AMRN) Weighed Down By ...: http://t.co/47TaTrNto4
catherine unwin
7 Jul 15 08:11:27
RT @P01YN0NYM0U55: ! @gnudarwin #California #SB277 is being used as test run for national law. Gotta tag #Merck and #GlaxoSmithKline ticker…
poly
7 Jul 15 08:09:54
! @gnudarwin #California #SB277 is being used as test run for national law. Gotta tag #Merck and #GlaxoSmithKline ticker symbols $MRK $GSK
wsnewspublishers
7 Jul 15 07:34:49
Active Stocks on the Move: http://t.co/fdDJTqiq6V $AINV $MMC $PRU $GSK
Trending Articles SA
7 Jul 15 07:00:06
Gilead's TAF-Based Drugs Or ViiV-GSK's Triumeq, Which Is Better? http://t.co/UEFpDub6S3 $GSK $JNJ $GILD
WLST.com
7 Jul 15 06:54:35
Is the Axovant IPO a Biotech Red Flag? $GSK #Axovant,GlaxoSmithKline,IPO,Schoenebaum,Tekmira http://t.co/bljDN00BlM http://t.co/Uof6zeQ6wH
marketexclusive
7 Jul 15 06:52:48
Is the Axovant IPO a Biotech Red Flag? - http://t.co/19dCnYXWmm $AXON $GSK #biotech #IPO
ValueWalk
7 Jul 15 06:41:32
SocGen's Piotroski Quant Value short picks for July http://t.co/iwytMocde0 $MO $GSK $POT $NBL @ruperthargreav1 http://t.co/eb1WXe7G6N
Bolt
7 Jul 15 06:31:16
@MarkSchoenebaum $AXON PhIII #Alzheimers 65% chance of success PT $60 & PT $2 if fail. http://t.co/nK7dxd0ejh $GSK $LLY $MRK $BIIB #biotech
Biotech Investor
7 Jul 15 06:15:03
Gilead's TAF-Based Drugs Or ViiV-GSK's Triumeq, Which Is Better? http://t.co/tVPok4P1yq $GSK $JNJ $GILD
Healthcare Stocks
7 Jul 15 06:15:03
Gilead's TAF-Based Drugs Or ViiV-GSK's Triumeq, Which Is Better? http://t.co/2r2qbRWDdM $GSK $JNJ $GILD
Long & Short Ideas
7 Jul 15 06:15:03
Gilead's TAF-Based Drugs Or ViiV-GSK's Triumeq, Which Is Better? http://t.co/OcAnEINuO5 $GSK $JNJ $GILD
Seeking Alpha
7 Jul 15 06:15:02
Gilead's TAF-Based Drugs Or ViiV-GSK's Triumeq, Which Is Better? http://t.co/UB4UfgRCUt $GSK $JNJ $GILD
Jbrack
7 Jul 15 06:08:59
RT @DDRANTE: @CNBC $PBMD Already in Partnership- $GSK & $NVS #IMP731 & #IMP701 ♥ $PBMD-If U like $KITE $JUNO $ADRO $ZIOP $ADSX http://t.c…
BUD RANTE
7 Jul 15 06:00:27
@CNBC $PBMD Already in Partnership- $GSK & $NVS #IMP731 & #IMP701 ♥ $PBMD-If U like $KITE $JUNO $ADRO $ZIOP $ADSX http://t.co/6vsMbLocg3
				
				
  +Follow August 16, 2013 9:54AM
Share:

Comments

 

blog comments powered by Disqus

 Today's Must Reads

Why More Millennials are Freaking Out About Money


"Entrepreneur Porn": Feeding the Indulgence of Wantrepreneurs

Trading Inverse ETFs

Everything You Need to Know About Volatility: Good, Bad, or Indifferent?

When to Help Your Loved Ones with Their Finances

 

Do you expect a 10% correction by the end of 2015? in Equities.com Polls on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register

LOG IN